RxSight, Inc. (RXST) reporting calendar
RxSight, Inc. files periodic reports with the SEC as RXST on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 27 Jul 2026 – 16 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 20
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001193125-26-208921 |
| 10-K | 31 Dec 2025 | 25 Feb 2026 | 56 days | 0001193125-26-071775 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001193125-25-266986 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0000950170-25-105070 |
| 10-Q | 31 Mar 2025 | 7 May 2025 | 37 days | 0000950170-25-065683 |
| 10-K | 31 Dec 2024 | 25 Feb 2025 | 56 days | 0000950170-25-026681 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-123368 |
| 10-Q | 30 Jun 2024 | 5 Aug 2024 | 36 days | 0000950170-24-090770 |
| 10-Q | 31 Mar 2024 | 6 May 2024 | 36 days | 0000950170-24-053566 |
| 10-K | 31 Dec 2023 | 28 Feb 2024 | 59 days | 0000950170-24-022073 |
| 10-Q | 30 Sep 2023 | 9 Nov 2023 | 40 days | 0000950170-23-062099 |
| 10-Q | 30 Jun 2023 | 7 Aug 2023 | 38 days | 0000950170-23-039081 |
| 10-Q | 31 Mar 2023 | 9 May 2023 | 39 days | 0000950170-23-019703 |
| 10-K | 31 Dec 2022 | 6 Mar 2023 | 65 days | 0000950170-23-006237 |
| 10-Q | 30 Sep 2022 | 7 Nov 2022 | 38 days | 0000950170-22-022617 |
| 10-Q | 30 Jun 2022 | 8 Aug 2022 | 39 days | 0000950170-22-015528 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0000950170-22-007878 |
| 10-K | 31 Dec 2021 | 8 Mar 2022 | 67 days | 0000950170-22-003135 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0000950170-21-004155 |
| 10-Q | 30 Jun 2021 | 9 Sep 2021 | 71 days | 0000950170-21-001744 |
Source: SEC EDGAR company submissions for CIK 0001111485. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.